Otsuka Holdings (4578) Stock Overview
Engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 6/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 5/6 |
| Dividends | 3/6 |
Rewards
Risk Analysis
4578 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Otsuka Holdings Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥7,007.00 |
| 52 Week High | JP¥9,669.00 |
| 52 Week Low | JP¥6,388.00 |
| Beta | 0.064 |
| 1 Month Change | 5.37% |
| 3 Month Change | -13.58% |
| 1 Year Change | 9.69% |
| 3 Year Change | 53.93% |
| 5 Year Change | 43.35% |
| Change since IPO | 227.43% |
Recent News & Updates
Otsuka Holdings (TSE:4578) Will Pay A Dividend Of ¥60.00
May 15
Results: Otsuka Holdings Co., Ltd. Beat Earnings Expectations And Analysts Now Have New Forecasts
May 03Recent updates
Otsuka Holdings (TSE:4578) Will Pay A Dividend Of ¥60.00
May 15Results: Otsuka Holdings Co., Ltd. Beat Earnings Expectations And Analysts Now Have New Forecasts
May 03Otsuka Holdings (TSE:4578) Will Pay A Dividend Of ¥60.00
May 01Otsuka Holdings (TSE:4578) Is Due To Pay A Dividend Of ¥60.00
Apr 13Do Otsuka Holdings' (TSE:4578) Earnings Warrant Your Attention?
Mar 21Results: Otsuka Holdings Co., Ltd. Exceeded Expectations And The Consensus Has Updated Its Estimates
Mar 01
New Product Launches And International Expansion May Offset Risks From JYNARQUE Exclusivity Loss
Expanding products in pharma and nutraceutical sectors aims to boost revenue, while aggressive international growth improves margins via economies of scale.The Strong Earnings Posted By Otsuka Holdings (TSE:4578) Are A Good Indication Of The Strength Of The Business
Feb 22Is Otsuka Holdings (TSE:4578) Using Too Much Debt?
Feb 03Calculating The Fair Value Of Otsuka Holdings Co., Ltd. (TSE:4578)
Jan 13Earnings Miss: Otsuka Holdings Co., Ltd. Missed EPS By 10% And Analysts Are Revising Their Forecasts
Nov 04Otsuka Holdings Co., Ltd.'s (TSE:4578) Price In Tune With Earnings
Oct 29Is Otsuka Holdings (TSE:4578) A Risky Investment?
Oct 07Calculating The Intrinsic Value Of Otsuka Holdings Co., Ltd. (TSE:4578)
Aug 26Otsuka Holdings Co., Ltd. Just Beat EPS By 57%: Here's What Analysts Think Will Happen Next
Aug 05Getting In Cheap On Otsuka Holdings Co., Ltd. (TSE:4578) Might Be Difficult
Jul 14Shareholder Returns
| 4578 | JP Pharmaceuticals | JP Market | |
|---|---|---|---|
| 7D | -3.4% | -3.0% | 0.6% |
| 1Y | 9.7% | -1.5% | 2.1% |
Return vs Industry: 4578 exceeded the JP Pharmaceuticals industry which returned -1.5% over the past year.
Return vs Market: 4578 exceeded the JP Market which returned 2.1% over the past year.
Price Volatility
| 4578 volatility | |
|---|---|
| 4578 Average Weekly Movement | 5.9% |
| Pharmaceuticals Industry Average Movement | 5.2% |
| Market Average Movement | 5.4% |
| 10% most volatile stocks in JP Market | 9.3% |
| 10% least volatile stocks in JP Market | 3.0% |
Stable Share Price: 4578 has not had significant price volatility in the past 3 months compared to the JP market.
Volatility Over Time: 4578's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1921 | 35,338 | Makoto Inoue | www.otsuka.com |
Otsuka Holdings Co., Ltd. engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide. The company develops pharmaceutical products in the fields of psychiatry, neurology, oncology, cardiovascular and renal system, digestive system, ophthalmology, and diagnostics, as well as intravenous solutions and medical devices. It also provides clinical testing, medical equipment, food products, cosmetics, functional food products, chemical products, soft drinks, beverages, analytical and measurement instruments, nutritional products, vehicle headlight testers, synthetic resin molded products, paper products, and insecticide and toiletry products.
Otsuka Holdings Co., Ltd. Fundamentals Summary
| 4578 fundamental statistics | |
|---|---|
| Market cap | JP¥3.70t |
| Earnings (TTM) | JP¥350.74b |
| Revenue (TTM) | JP¥2.39t |
Is 4578 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4578 income statement (TTM) | |
|---|---|
| Revenue | JP¥2.39t |
| Cost of Revenue | JP¥665.28b |
| Gross Profit | JP¥1.73t |
| Other Expenses | JP¥1.38t |
| Earnings | JP¥350.74b |
Last Reported Earnings
Mar 31, 2025
Next Earnings Date
Jul 31, 2025
| Earnings per share (EPS) | 664.22 |
| Gross Margin | 72.20% |
| Net Profit Margin | 14.66% |
| Debt/Equity Ratio | 6.0% |
How did 4578 perform over the long term?
See historical performance and comparisonDividends
Does 4578 pay a reliable dividends?
See 4578 dividend history and benchmarks| Otsuka Holdings dividend dates | |
|---|---|
| Ex Dividend Date | Jun 27 2025 |
| Dividend Pay Date | Sep 02 2025 |
| Days until Ex dividend | 4 days |
| Days until Dividend pay date | 71 days |
Does 4578 pay a reliable dividends?
See 4578 dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/06/22 22:26 |
| End of Day Share Price | 2025/06/20 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Otsuka Holdings Co., Ltd. is covered by 18 analysts. 12 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Atsushi Seki | Barclays |
| Koichi Mamegano | BofA Global Research |
| Hidemaru Yamaguchi | Citigroup Inc |